Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases

Frontiers in Molecular Neuroscience

Volumn 6, Issue DEC, 2013, Pages

  Martf, Eulàlia ^a,b   Estivill, Xavier ^a,b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Antisense small RNA; MiRNA; RNA toxicity; Small non coding RNAs; Trinucleotide repeat expansion

Indexed keywords

ATAXIN 1; ATAXIN 3; ATAXIN 7; CHLORIDE CHANNEL; FRAGILE X MENTAL RETARDATION PROTEIN; FRATAXIN; HUNTINGTIN; JUCTOPHILIN 3; MICRORNA; MUSCLEBLIND LIKE SPLICING REGULATOR1; MYOTONIC DYSTROPHY PROTEIN KINASE; PEPTIDES AND PROTEINS; POLYGLUTAMINE; SMALL UNTRANSLATED RNA; TATA BINDING PROTEIN; UBIDECARENONE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; BIOGENESIS; CAG REPEAT; GENE LOCUS; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; HUNTINGTON DISEASE LIKE SYNDROME; NONHUMAN; PATHOGENESIS; REVIEW; TOXICITY; TRINUCLEOTIDE REPEAT EXPANSION DISEASE;

EID: 84889567773     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2013.00045     Document Type: Review

References (116)

1. Alvarez-Mora, M. I., Rodriguez-Revenga, L., Madrigal, I., Torres-Silva, R, Mateu-Huertas, E., Lizano, E., et al. (2013). MicroRNA expression profiling in blood from fragile X-associated tremor/ataxia syndrome patients. Genes Brain Behav. 12, 595-603. doi: 10.1111/gbb.12061
2. Banez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., etal. (2012). A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet 8:e1002481. doi: 10.1371/journal.pgen.1002481
3. Batra, R., Charizanis, K., and Swanson, M. S. (2010). Partners in crime: bidirectional transcription in unstable microsatellite disease. Hum. Mol. Genet. 19,R77-82. doi: 10.1093/hmg/ddql32
4. Beal, M. F. (2002). Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic. Res. 36, 455-460. doi: 10.1080/10715760290021315
5. Bilen, J., Liu, N., Burnett, B. G., Pittman, R. N., and Bonini, N. M. (2006). MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol. Cell 24, 157-163. doi: 10.1016/j.molcel.2006.07.030
6. Boudreau, R. L., Spengler, R. M., and Davidson, B. L. (2011). Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease. Mol. Ther. 19, 2169-2177. doi: 10.1038/mt.2011.185
7. ; end of a transcript encoding a protein kinase family member. Cell 69,385. doi: 10.1016/0092-8674(92)90154-5
8. Brusco, A., Cagnoli, C., Franco, A., Dragone, E., Nardacchione, A., Grosso, E., et al. (2002). Analysis of SCA8 and SCA12 loci in 134 Italian ataxic patients negative for SCA1-3, 6 and 7 CAG expansions. J. Neurol 249, 923-929. doi: 10.1007/s00415-002-0760-y
9. Carroll, J. B.,Warby, S. C, Southwell, A. L., Doty, C. N., Greenlee, S.,Skotte, N.,et al. (2011). Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene/allele-specific silencing of mutant huntingtin. Mol. Ther. 19, 2178-2185. doi: 10.1038/mt.2011.201
10. Chen, J., Sun, M., Kent, W. J., Huang, X., Xie, H., Wang, W., etal. (2004). Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Res. 32, 4812-4820. doi: 10.1093/nar/gkh818
11. Cho, D. H., Thienes, C. P., Mahoney, S. E., Analau, E., Filippova, G. N., and Tapscott, S. J. (2005). Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 20, 483-489. doi: 10.1016/j.molcel.2005.09.002
12. Chung, D.W., Rudnicki, D. D.,Yu, L., and Margolis, R. L. (2011). A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Hum. Mol. Genet. 20, 3467-3477. doi: 10.1093/hmg/ddr263
13. Clabough, E. B. (2013). Huntington's disease: the past, present, and future search for disease modifiers. YaleJ. Biol. Med. 86, 217-233.
14. Daughters, R. S., Tuttle, D. L., Gao, W., Ikeda, Y., Moseley, M. L., Ebner, T. J., et al. (2009). RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 5:el000600. doi: 10.1371/journal.pgen.1000600
15. Day, J. W., Schut, L. J., Moseley, M. L., Durand, A. C, and Ranum, L. P. (2000). Spinocerebellar ataxia type 8: clinical features in a large family. Neurology 55, 649-657. doi: 10.1212/WNL.55.5.649
16. de Almeida, L. P., Zala, D., Aebischer, P., and Deglon, N. (2001). Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol Dis. 8, 433-446. doi: 10.1006/nbdi.2001.0388
17. de Mezer, M., Wojciechowska, M., Napierala, M., Sobczak, K., and Krzyzosiak, W. J. (2011). Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res. 39, 3852-3863. doi: 10.1093/nar/gkq1323
18. Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789. doi: 10.1101/gr.132159.111
19. Ellegren, H. (2004). Microsatellites: simple sequences with complex evolution. Nat. Rev. Genet. 12, 861-874. doi: 10.1038/nrg3074
20. Fernandez-Costa, J. M., Garcia-Lopez, A., Zuñiga, S., Fernandez-Pedrosa, V., Felipo-Benavent, A., Mata, M., et al. (2013). Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients. Hum. Mol. Genet. 22, 704-716. doi: 10.1093/hmg/dds478
21. Fiszer, A., Olejniczak, M., Switonski, P. M., Wroblewska, J. P., Wisniewska-Kruk, J., Mykowska, A., et al. (2012). An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases. BMC Mol. Biol. 13:6. doi: 10.1186/1471-2199-13-6
22. Fugier, C., Klein, A. F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., et al. (2011). Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med. 17, 720-725. doi: 10.1038/nm.2374
23. Fukuda, T., Yamagata, K., Fujiyama, S., Matsumoto, T., Koshida, I., Yoshimura, K., et al. (2007). DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat. Cell Biol. 9, 604-611. doi: 10.1038/ncb1577
24. Gagnon, K. T., Pendergraff, H. M., Deleavey, G. F., Swayze, E. E., Potier, P., Randolph, J., et al. (2010). Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry 49, 10166-10178. doi: 10.1021/bi101208k
25. Galka-Marciniak, P., Urbanek, M. O., and Krzyzosiak, W. J. (2012). Triplet repeats in transcripts: structural insights into RNA toxicity. Biol. Chem. 393, 1299-1315. doi: 10.1515/hsz-2012-0218
26. Godin, J. D., Colombo, K., Molina-Calavita, M., Keryer, G., Zala, D., Charrin, B. C., et al. (2010). Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67, 392-406. doi: 10.1016/j.neuron.2010.06.027
27. Gomes-Pereira, M., Foiry, L., Nicole, A., Huguet, A., Junien, C., Munnich, A., et al. (2007). CTG trinucleotide repeat "big jumps": large expansions, small mice. PLoS Genet. 3:e52. doi: 10.1371/journal.pgen.0030052
28. Gray, S. G. (2010). Targeting histone deacetylases for the treatment of Huntington's disease. CNS Neurosci. Ther. 16, 348-361 doi: 10.1111/j.1755-5949.2010.00184.x
29. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., et al. (2004). The microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240. doi: 10.1038/nature03120
30. Hagerman, P. J., and Hagerman, R. J. (2004). The Fragile-X premutation: a maturing perspective. Am. J. Hum. Genet. 75, 352.
31. Handa, V., Saha, T., and Usdin, K. (2003). The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res. 31, 6243-6248. doi: 10.1093/nar/gkg818
32. Haramati, S., Chapnik, E., Sztainberg, Y., Eilam, R., Zwang, R., Gershoni, N., et al. (2010). miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 107, 13111-13116. doi: 10.1073/pnas.1006151107
33. Harper, S. Q., Staber, P. D., He, X., Eliason, S. L., Martins, I. H., Mao, Q., et al. (2005). RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. U.S.A. 102, 5820-5825. doi: 10.1073/pnas.0501507102
34. He, Y., Vogelstein, B., Velculescu, V. E., Papadopoulos, N., and Kinzler, K. W. (2008). The antisense transcriptomes of human cells. Science 322, 1855-1857. doi: 10.1126/science.1163853
35. Holmes, S. E., O'Hearn, E., Rosenblatt, A., Callahan, C., Hwang, H. S., Ingersoll-Ashworth, R. G., et al. (2001). A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 29, 377-378. doi: 10.1038/ng760
36. Hsu, R. J., Hsiao, K. M., Lin, M. J., Li, C. Y., Wang, L. C., Chen, L. K., et al. (2011). Long tract of untranslated CAG repeats is deleterious in transgenic mice. PLoS ONE 6:e16417. doi: 10.1371/journal.pone.0016417
37. Hu, J., Dodd, D. W., Hudson, R. H., and Corey, D. R. (2009a). Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy)phenyl]pyrrolocytosine. Bioorg. Med. Chem. Lett. 19, 6181-6184. doi: 10.1016/j.bmcl.2009.09.004
38. Hu, J., Matsui, M., and Corey, D. R. (2009b). Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA. Ann. N. Y. Acad. Sci. 1175, 24-31. doi: 10.1111/j.1749-6632.2009.04975.x
39. Hu, J., Matsui, M., Gagnon, K. T., Schwartz, J. C., Gabillet, S., Arar, K., et al. (2009c). Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat. Biotechnol. 27, 478-484. doi: 10.1038/nbt.1539
40. Huang, K., Sanders, S. S., Kang, R., Carroll, J. B., Sutton, L., Wan, J., et al. (2011). Wild-type HTT modulates the enzymatic activity of the neu-ronal palmitoyl transferase HIP14. Hum. Mol. Genet. 20, 3356-3365. doi: 10.1093/hmg/breakddr242
41. Huguet, A., Medja, F., Nicole, A., Vignaud, A., Guiraud-Dogan, C., Ferry, A., et al. (2012). Molecular, physiological, and motor performance defects in DMSXL mice carrying > 1,000 CTG repeats from the human DM1 locus. PLoS Genet. 8:e1003043. doi: 10.1371/journal.pgen.1003043
42. Iwahashi, C. K., Yasui, D. H., An, H. J., Greco, C. M., Tassone, F., Nannen, K., et al. (2006). Protein composition of the intranuclear inclusions of FXTAS. Brain 129, 256-271. doi: 10.1093/brain/awh650
43. Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T., and Thornton, C. A. (2004). Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13, 3079-3088. doi: 10.1093/hmg/ddh327
44. Jin, P., Duan, R., Qurashi, A., Qin, Y., Tian, D., Rosser, T. C., et al. (2007). Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55, 556-564. doi: 10.1016/j.neuron.2007.07.020
45. Karres, J. S., Hilgers, V., Carrera, I., Treisman, J., and Cohen, S. M. (2007). The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 131, 136-145. doi: 10.1016/j.cell.2007.09.020
46. Khalili, K., Del Valle, L., Muralidharan, V., Gault, W. J., Darbinian, N., Otte, J., et al. (2003). Puralpha is essential for postnatal brain development and develop-mentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol. Cell. Biol. 23, 6857-6875. doi: 10.1128/MCB.23.19.6857-6875.2003
47. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., et al. (2007). A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224. doi: 10.1126/science.1140481
48. Koob, M. D., Moseley, M. L., Schut, L. J., Benzow, K. A., Bird, T. D., Day, J. W., et al. (1999). An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 21, 379-384. doi: 10.1038/7710
49. Kordasiewicz, H. B., Stanek, L. M., Wancewicz, E. V., Mazur, C., McAlonis, M. M., Pytel, K. A., et al. (2012). Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron 74, 1031-1044. doi: 10.1016/j.neuron.2012.05.009
50. Krol, J., Fiszer, A., Mykowska, A., Sobczak, K., de Mezer, M., and Krzyzosiak, W. J. (2007). Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol. Cell 25, 575-586. doi: 10.1016/j.molcel.2007. 01.031
51. Krzyzosiak, W. J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A., and Kozlowski, P. (2012). Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res. 40, 11-26. doi: 10.1093/nar/gkr729
52. Kuyumcu-Martinez, N. M., Wang, G. S., and Cooper, T. A. (2007). Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 28, 68-78. doi: 10.1016/j.molcel.2007.07.027
53. Ladd, P. D., Smith, L. E., Rabaia, N. A., Moore, J. M., Georges, S. A., Hansen, R. S., et al. (2007). An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 16, 3174-3187. doi: 10.1093/hmg/ddm293
54. Laurent, F. X., Sureau, A., Klein, A. F., Trouslard, F., Gasnier, E., Furling, D., et al. (2012). New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic Acids Res. 40, 3159-3171. doi: 10.1093/nar/gkr1228
55. Lawlor, K. T., O'Keefe, L. V., Samaraweera, S. E., van Eyk, C. L., McLeod, C. J., Maloney, C. A., et al. (2011). Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases. Hum. Mol. Genet. 20, 3757-3768. doi: 10.1093/hmg/ddr292
56. Lee, Y., Samaco, R. C., Gatchel, J. R., Thaller, C., Orr, H. T., and Zoghbi, H. Y. (2008). miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat. Neurosci. 11, 1137-1139. doi: 10.1038/nn.2183
57. Li, L. B., Yu, Z., Teng, X., and Bonini, N. M. (2008). RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 1107-1111. doi: 10.1038/nature06909
58. Li, Y., Yokota, T., Matsumura, R., Taira, K., and Mizusawa, H. (2004). Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA. Ann. Neurol. 56, 124-129. doi: 10.1002/ana.20141
59. Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G. J., Kennerdell, J. R., et al. (2012). The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482, 519-523. doi: 10.1038/nature10810
60. Loesch, D. Z., Godler, D. E., Evans, A., Bui, Q. M., Gehling, F., Kotschet, K. E., et al. (2011). Evidence for the toxicity of bidirectional transcripts and mito-chondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genet. Med. 13, 392-399. doi: 10.1097/GIM.0b013e3182064362
61. Lombardi, M. S., Jaspers, L., Spronkmans, C., Gellera, C., Taroni, F., Di Maria, E., et al. (2009). A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference. Exp. Neurol. 217, 312-319. doi: 10.1016/j.expneurol.2009.03.004
62. Mahishi, L. H., Hart, R. P., Lynch, D. R., and Ratan, R. R. (2012). miR-886-3p levels are elevated in Friedreich ataxia. J. Neurosci. 32, 9369-9373. doi: 10.1523/JNEUROSCI.0059-12.2012
63. Martí, E., Pantano, L., Banez-Coronel, M., Llorens, F., Minones-Moyano, E., Porta, S., et al. (2010). A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 38, 7219-7235. doi: 10.1093/nar/gkq575
64. McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Monteys, A. M., Martins, I., et al. (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U.S.A. 105, 5868-5873. doi: 10.1073/pnas.0801775105
65. McCann, C., Holohan, E. E., Das, S., Dervan, A., Larkin, A., Lee, J. A., et al. (2011). The Ataxin-2 protein is required for microRNA function and synapse-specific long-term olfactory habituation. Proc. Natl. Acad. Sci. U.S.A. 108, E655-E662. doi: 10.1073/pnas.1107198108
66. Mittoux, V., Joseph, J. M., Conde, F., Palfi, S., Dautry, C., Poyot, T., et al. (2000). Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Hum. Gene Ther. 11, 1177-1187. doi: 10.1089/10430340050015220
67. Morris, K. V., Santoso, S., Turner, A. M., Pastori, C., and Hawkins, P. G. (2008). Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet. 4:e1000258. doi: 10.1371/jour-nal.pgen.1000258
68. Moseley, M. L., Zu, T., Ikeda, Y., Gao, W., Mosemiller, A. K., Daughters, R. S., et al. (2006). Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat. Genet. 38, 758-769. doi: 10.1038/ng1827
69. Mulders, S. A., van den Broek, W. J., Wheeler, T. M., Croes, H. J., van Kuik-Romeijn, P., de Kimpe, S. J., et al. (2009). Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. U.S.A. 106, 13915-13920. doi: 10.1073/pnas.0905780106
70. Mykowska, A., Sobczak, K., Wojciechowska, M., Kozlowski, P., and Krzyzosiak, W. J. (2011). CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res. 39, 8938-8951. doi: 10.1093/nar/gkr608
71. O'Carroll, D., and Schaefer, A. (2013). General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology 38, 39-54. doi: 10.1038/npp.2012.87
72. Omi, K., Hachiya, N. S., Tokunaga, K., and Kaneko, K. (2005). siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro. Biochem. Biophys. Res. Commun. 338, 1229-1235. doi: 10.1016/j.bbrc.2005.10.061
73. Orr, H. T., and Zoghbi, H. Y. (2007). Trinucleotide repeat disorders. Annu. Rev. Neurosci. 39, 373-379. doi: 10.1146/annurev.neuro.29.051605.113042
74. Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., and Davidson, B. L. (2008). The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 28, 14341-14346. doi: 10.1523/JNEUROSCI.2390-08.2008
75. Perez-Navarro, E., Canudas, A. M., Akerund, P., Alberch, J., and Arenas, E. (2000). Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J. Neurochem. 75, 2190-2199. doi: 10.1046/j.1471-4159.2000.0752190.x
76. Persengiev, S., Kondova, I., Otting, N., Koeppen, A. H., and Bontrop, R. E. (2011). Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol. Aging 32, 2316, e2317-e2327. doi: 10.1016/j.neurobiolaging.2010.03.014
77. Pfister, E. L., Kennington, L., Straubhaar, J., Wagh, S., Liu, W., DiFiglia, M., et al. (2009). Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. Curr. Biol. 19, 774-778. doi: 10.1016/j.cub.2009.03.030
78. Pouladi, M. A., Stanek, L. M., Xie, Y., Franciosi, S., Southwell, A. L., Deng, Y., et al. (2012). Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum. Mol. Genet. 21, 2219-2232. doi: 10.1093/hmg/dds037
79. Ranum, L. P., and Cooper, T. A. (2006). RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 29, 259-277. doi: 10.1146/annurev.neuro.29.051605.113014
80. Rau, F., Freyermuth, F., Fugier, C., Villemin, J. P., Fischer, M. C., Jost, B., et al. (2011). Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat. Struct. Mol. Biol. 18, 840-845. doi: 10.1038/nsmb.2067
81. Rodriguez-Lebron, E., Denovan-Wright, E. M., Nash, K., Lewin, A. S., and Mandel, R. J. (2005). Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618-633. doi: 10.1016/j.ymthe.2005.05.006
82. Rodriguez-Lebron, E., Liu, G., Keiser, M., Behlke, M. A., and Davidson, B. L. (2013). Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Neurobiol. Dis. 54, 456-463. doi: 10.1016/j.nbd.2013. 01.019
83. Rudnicki, D. D., Holmes, S. E., Lin, M. W., Thornton, C. A., Ross, C. A., and Margolis, R. L. (2007). Huntington's disease - like 2 is associated with CUG repeat-containing RNA foci. Ann. Neurol. 61, 272-282. doi: 10.1002/ana.21081
84. Sah, D. W., and Aronin, N. (2011). Oligonucleotide therapeutic approaches for Huntington disease. J. Clin. Invest. 121, 500-507. doi: 10.1172/JCI45130
85. Savas, J. N., Makusky, A., Ottosen, S., Baillat, D., Then, F., Krainc, D., et al. (2008). Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc. Natl. Acad. Sci. U.S.A. 105, 10820-10825. doi: 10.1073/pnas.0800658105
86. Schaefer, A., O'Carroll, D., Tan, C. L., Hillman, D., Sugimori, M., Llinas, R., et al. (2007). Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204, 1553-1558. doi: 10.1084/jem.20070823
87. Scholefield, J., Greenberg, L. J., Weinberg, M. S., Arbuthnot, P. B., Abdelgany, A., and Wood, M. J. (2009). Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype. PLoS ONE 4:e7232. doi: 10.1371/journal.pone.0007232
88. Schwarz, D. S., Ding, H., Kennington, L., Moore, J. T., Schelter, J., Burchard, J., et al. (2006). Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet. 2:e140. doi: 10.1371/journal.pgen.0020140
89. Seixas, A. I., Holmes, S. E., Takeshima, H., Pavlovich, A., Sachs, N., Pruitt, J. L., et al. (2012). Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Ann. Neurol. 71, 245-257. doi: 10.1002/ana.22598
90. Sellier, C., Freyermuth, F., Tabet, R., Tran, T., He, F., Ruffenach, F., et al. (2013). Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep. 3, 869-880. doi: 10.1016/j.celrep.2013.02.004
91. Sellier, C., Rau, F., Liu, Y., Tassone, F., Hukema, R.K., Gattoni, R., et al. (2010). Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 29, 1248-1261. doi: 10.1038/emboj.2010.21
92. Shin, D., Shin, J. Y., McManus, M. T., Ptacek, L. J., and Fu,Y. H. (2009). Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 66, 843-857. doi: 10.1002/ana.21927
93. Shiohama, A., Sasaki, T., Noda, S., Minoshima, S., and Shimizu, N. (2003). Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochem. Biophys. Res. Commun. 304, 184-190. doi: 10.1016/S0006-291X(03)00554-0
94. Sofola, O. A., Jin, P., Qin, Y., Duan, R., Liu, H., de Haro, M., et al. (2007). RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG pre-mutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55, 565-571. doi: 10.1016/j.neuron.2007.07.021
95. Sopher, B. L., Ladd, P. D., Pineda, V. V., Libby, R. T., Sunkin, S. M., Hurley, J. B., et al. (2011). CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron 70, 1071-1084. doi: 10.1016/j.neuron.2011.05.027
96. Southwell, A. L., Ko, J., and Patterson, P. H. (2009). Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease. J. Neurosci. 29, 13589-13602. doi: 10.1523/JNEUROSCI.4286-09.2009
97. Stark, K. L., Xu, B., Bagchi, A., Lai, W. S., Liu, H., Hsu, R., et al. (2008). Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751-760. doi: 10.1038/ng.138
98. Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., et al. (2001). Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743. doi: 10.1038/35099568
99. Tao, J., Wu, H., Lin, Q., Wei, W., Lu, X. H., Cantle, J. P., et al. (2011). Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 31, 8306-8319. doi: 10.1523/JNEUROSCI.0567-11.2011
100. Todd, P. K., Oh, S. Y., Krans, A., He, F., Sellier, C., Frazer, M., et al. (2013). CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78, 440-455. doi: 10.1016/j.neuron.2013.03.026
101. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914. doi: 10.1016/0092-8674(91)90397-H
102. Wang, L. C., Chen, K. Y., Pan, H., Wu, C. C., Chen, P. H., Liao, Y. T., et al. (2011). Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans. Cell. Mol. Life Sci 68, 1255-1267. doi: 10.1007/s00018-010-0522-4
103. Warby, S. C., Montpetit, A., Hayden, A. R., Carroll, J. B., Butland, S. L., Visscher, H., et al. (2009). CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am. J. Hum. Genet. 84, 351-366. doi: 10.1016/j.ajhg.2009.02.003
104. Watts, J. K., and Corey, D. R. (2012). Silencing disease genes in the laboratory and the clinic. J. Pathol. 226, 365-379. doi: 10.1002/path.2993
105. Wheeler, T. M., Leger, A. J., Pandey, S. K., MacLeod, A. R., Nakamori, M., Cheng, S. H., et al. (2012). Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111-115. doi: 10.1038/nature11362
106. Wheeler, T. M., and Thornton, C. A. (2007). Myotonic dystrophy: RNA-mediated muscle disease. Curr. Opin. Neurol 20, 572-576. doi: 10.1097/WCO.0b013e3282ef6064
107. Wilburn, B., Rudnicki, D. D., Zhao, J., Weitz, T. M., Cheng, Y., Gu, X., et al. (2011). An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron 70, 427-440. doi: 10.1016/j.neuron.2011.03.021
108. Xu, S., Zhang, R., Niu, J., Cui, D., Xie, B., Zhang, B., et al. (2012). Oxidative stress mediated-alterations of the microRNA expression profile in mouse hippocampal neurons. Int. J. Mol. Sci. 13, 16945-16960. doi: 10.3390/ijms131216945
109. Yanagisawa, H., Bundo, M., Miyashita, T., Okamura-Oho, Y., Tadokoro, K., Tokunaga, K.,et al. (2000). Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine. Hum. Mol. Genet. 9, 1433-1442. doi: 10.1093/hmg/9.9.1433
110. Yu, D., Pendergraff, H., Liu, J., Kordasiewicz, H. B., Cleveland, D. W., Swayze, E. E., et al. (2012). Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell 150, 895-908. doi: 10.1016/j.cell.2012.08.002
111. Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P., et al. (2008). Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206. doi: 10.1038/nature06468
112. Yu, Z., Teng, X., and Bonini, N. M. (2011). Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genet. 7:e1001340. doi: 10.1371/journal.pgen.1001340
113. Yuan, Y., Compton, S. A., Sobczak, K., Stenberg, M. G., Thornton, C. A., Griffith, J. D., et al. (2007). Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 35, 5474-5486. doi: 10.1093/nar/gkm601
114. Zheng, Z., and Diamond, M. I. (2012). Huntington disease and the huntingtin protein. Prog. Mol Biol. Transl. Sci. 107, 189-214. doi: 10.1016/B978-0-12-385883-2.00010-2
115. ; UTR of FMR1 mRNA is a target of miR-101, miR-129-5p andmiR-221: implications for the molecular pathology of FXTAS at the synapse. Hum. Mol. Genet. 22, 1971-1982. doi: 10.1093/hmg/ddt044
116. Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D., et al. (2011). Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. U.S.A. 108, 260-265. doi: 10.1073/pnas.1013343108